Tag Archives: careers

Deep learning predicts a woman’s risk of breast cancer

[ad_1] OAK BROOK, Ill., November 30, 2020 / PRNewswire / – Massachusetts General Hospital (MGH) researchers have developed a deep learning model that identifies imaging biomarkers on mammography screening to predict a patient’s risk of developing breast cancer more accurately than traditional assessment tools risk. The results of the study …

Read More »

Discovery of potential treatment against antibiotic-resistant bacteria that cause gonorrhea and meningitis

[ad_1] MONTREAL is LAVAL, November 24, 2020 / CNW Telbec / – A team from National Institute for Scientific Research (INRS) demonstrated the effectiveness of an inexpensive molecule to fight antibiotic-resistant strains of the bacteria responsible for gonorrhea and meningococcal meningitis. These two infections affect millions of people around the …

Read More »

Contestant dies after filming ‘Wipeout’ obstacle show

[ad_1] A well-known competitor obstacle television program “Wipeout” He died last Wednesday after suffering a heart attack after finishing one of the competition races. According to sources from the show’s production at Variety magazine, the competitor requested medical attention after finishing the test, was treated on the recording set and, …

Read More »

Innovent announces Phase I clinical trial results of IBI302, a first-class anti-VEGF and anti-complement ophthalmic recombinant human bi-specific fusion protein for age-related neovascular macular degeneration at 2020 AAO

[ad_1] SAN FRANCISCO and SUZHOU, China, November 15, 2020 / PRNewswire / – Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and markets high-quality medicines for the treatment of oncological, metabolic, autoimmune and other major diseases, announces that the results of Phase Clinical I The …

Read More »

SSRI antidepressants may be effective early treatments for COVID-19

[ad_1] Researchers at Washington University School of Medicine in St. Louis published the results of a clinical trial evaluating an antidepressant, fluvoxamine, for early treatment for COVID-19. The study was published in JAMA, The Journal of the American Medical Association, and was funded by the COVID-19 Early Treatment Fund (CETF). …

Read More »